IMC Chicago’s Ginkgo Bioworks DNA Stock Holding History

IMC Chicago’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$159K	Sell	26,000 -22,000	-46%	-$183K	﹤0.01%	5141
2025 Q4	$399K	Buy	48,000 +7,400	+18%	+$79.7K	﹤0.01%	3618
2025 Q3	$592K	Buy	+40,600	New	+$486K	﹤0.01%	3061

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's DNA Position: Q1 2026 in Review

IMC Chicago opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 20,501 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #5251 among its holdings.

174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

IMC Chicago held 20,501 shares of Ginkgo Bioworks worth $126K as of Q1 2026.
Ginkgo Bioworks was a new IMC Chicago position in Q1 2026.
Ginkgo Bioworks made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5251 holding.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.